Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire made its biggest ever acquisition yet in January 2015 with a $5.2 billion deal for US biotechnology company NPS Pharmaceuticals. The move came a few months after the group's sale to rival AbbVie collapsed.
Financial Data
-
31st Dec 18 Source: CRO
- €13.7 billion turnover
-
€2.4 billion
profit - 22,000 employees
-
31st Dec 17 Source: CRO
- €12.4 billion turnover
-
€3.5 billion
profit - 22,000 employees
- 10 more years available »
Ranking
By Turnover
(€13.7 billion)- 12th in Top Companies
- 2nd in Pharma
By Employees
(22,000)- 8th in Top Companies
- 1st in Pharma
-
- 22,000
- €13.7 billion
Employees
- Flemming Ornskov CEO/Managing Director
Latest News
- 5:31pm Europe is poised to lead global growth in electric-car sales
- 1:49pm Peter Bellew claims he averted safety finding against Ryanair
- 1:49pm Michael O’Leary ‘screamed and shouted’ at some staff, court told
- 1:41pm Saudi Aramco touches $2tn valuation on second day of trading
- 1:17pm ECB keeps policy unchanged with door still open to more stimulus